Skip to main content

Diversified Insulin-Associated Beta-Behavioral and Endogenously Triggered Exposed Symptoms (DIABETES) Model of Diabetes in India

  • 934 Accesses

Part of the SpringerBriefs in Applied Sciences and Technology book series (BRIEFSFOMEBI)

Abstract

The objective of the paper was to propose a diversified insulin-associated beta-behavioral and endogenously triggered exposed symptoms (DIABETES) model due to multiple factors so as to suggest medical remedies to improve the avoidance of diabetes disease. The various causes and their chances toward the most common diabetes effects including deaths in the nation are modeled as an diversified insulin association. The regional, social, biological and cultural aspects of the Indian community are considered to model the diabetes that of different categories. The performance and the correctness of the model are determined by considering the heterogeneity due to different factors that are specified as proposed IAB-ETES process algebra. The model-driven approach needs restricted operations on the variables to supplement any health care information system. The individual human responsibility and societal awareness along with the health regulation acts can minimize the vulnerability of the disease if the information technology for biological system complies with the enforcement acts of the developing nation.

Keywords

  • Diversification
  • Association
  • Endogenous
  • Exposed
  • Cultural
  • Causality
  • Causes and outcomes

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-981-287-338-5_1
  • Chapter length: 15 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   54.99
Price excludes VAT (USA)
  • ISBN: 978-981-287-338-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   69.99
Price excludes VAT (USA)
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Whiting D, Unwin N, Roglic G (2010) Diabetes: equity and social determinants. In: Blas E, Kurup A (eds) Equity, social determinants and public health programmes. World Health Organization, pp 77–94

    Google Scholar 

  2. Goldstein J, Jacoby E, del Aguila R et al (2005) Poverty is a predictor of non-communicable disease among adults in Peruvian cities. Prev Med 41(3–4):800–806

    CrossRef  Google Scholar 

  3. Wild S, Roglic G, Green A et al (2004) Global prevalence of diabetes. Diabetes Care 27:1047–1053

    CrossRef  Google Scholar 

  4. Shobhana R, Rao PR, Lavanya A et al (2000) Expenditure on health care incurred by diabetic subjects in a developing country–a study from southern India. Diabetes Res Clin Pract 48(1):37–42

    CrossRef  Google Scholar 

  5. Hawkes C (2005) The role of foreign direct investment in the nutrition transition. Public Health Nutr 8(4):357–365

    CrossRef  Google Scholar 

  6. Knowler WC, Connor EB, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England J Med 346(6):393–403

    CrossRef  Google Scholar 

  7. Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes prevention study (dps): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26(12):3230–3236

    CrossRef  Google Scholar 

  8. Gillespie D (2008) Sweet poison: why sugar makes you fat. p 118, ISBN 978-0-670-07247-7

    Google Scholar 

  9. Keys A (1970) Coronary heart disease in seven countries. American Heart Association, New York

    Google Scholar 

  10. Uemura K, Pisa Z (1988) Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 41:155–178

    Google Scholar 

  11. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J (2000) International trends in mortality from stroke 1968 to 1994. Stroke 31:1588–1601

    CrossRef  Google Scholar 

  12. The Merck Manual of Medical Information (2003) Diabetes mellitus. p 962, ISBN 978-0-7434-7733-8

    Google Scholar 

  13. Cerasi E, Luft R (1967) The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol (Copeh.) 55:278–304

    Google Scholar 

  14. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC (1989) Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38:767–772

    CrossRef  Google Scholar 

  15. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110

    CrossRef  Google Scholar 

  16. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Clément K, Fougerousse F et al (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162–164

    CrossRef  Google Scholar 

  17. Supale S, Li N, Brun T, Maechler P (2012) Mitochondrial dysfunction in pancreatic β cells. Trends Endocrinol Metab 23:477–487

    CrossRef  Google Scholar 

  18. Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351–42354

    CrossRef  Google Scholar 

  19. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patanè G, Laybutt R, Bonner-Weir S, Weir GC (1999) Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121

    CrossRef  Google Scholar 

  20. Fittante A (2007) Prevention’s the sugar solution. p 264, ISBN 1-59486-693-7

    Google Scholar 

  21. CDC Diabetes and me. http://www.cdc.gov/diabetes/consumer/learn.htm

  22. CDC Prevent diabetes. http://www.cdc.gov/diabetes/consumer/prevent.htm

  23. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355:675–687. (CrossRefMedlineWeb of Science http://bmb.oxfordjournals.org/external-ref?access_num=10703799&link_type=MED)

  24. Eriksson KF, Lindgarde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34:891–898. (CrossRefMedlineWeb of Science http://bmb.oxfordjournals.org/external-ref?access_num=A1991GV96700006&link_type=ISI)

  25. Bloom garden ZT (2004) Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 27:998–1010

    CrossRef  Google Scholar 

  26. Fagot-Campagna A, Pettitt DJ, Engelgau MM et al (2000) Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136:664–672

    CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Raja Rajeswari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2015 The Author(s)

About this chapter

Cite this chapter

Raja Rajeswari, P., Subramaniam, C., Appa Rao, A. (2015). Diversified Insulin-Associated Beta-Behavioral and Endogenously Triggered Exposed Symptoms (DIABETES) Model of Diabetes in India. In: Muppalaneni, N., Gunjan, V. (eds) Computational Intelligence Techniques for Comparative Genomics. SpringerBriefs in Applied Sciences and Technology(). Springer, Singapore. https://doi.org/10.1007/978-981-287-338-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-338-5_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-337-8

  • Online ISBN: 978-981-287-338-5

  • eBook Packages: EngineeringEngineering (R0)